BioGenCell Ltd.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Holding
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://biogencell.net
BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
Phase 1
Recruiting
- Conditions
- Chronic Limb-Threatening IschemiaPeripheral Arterial DiseasePeripheral Vascular Disease
- Interventions
- Biological: Control mediumBiological: BGC101 (autologous EnEPC preparation)
- First Posted Date
- 2016-06-17
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- BioGenCell Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT02805023
- Locations
- 🇮🇱
Laniado Hospital, Netanya, Israel
🇺🇸University of San Francisco, San Francisco, California, United States
🇺🇸Johns Hopkins Hospital, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath